2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities for ultra-rare inherited bleeding disorders

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Most cited references75

          • Record: found
          • Abstract: not found
          • Article: not found

          WFH Guidelines for the Management of Hemophilia, 3rd edition

            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders.

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Rare Disease Terminology and Definitions-A Systematic Global Review: Report of the ISPOR Rare Disease Special Interest Group.

              At present, there is no universal definition of rare disease.
                Bookmark

                Author and article information

                Contributors
                (View ORCID Profile)
                (View ORCID Profile)
                (View ORCID Profile)
                (View ORCID Profile)
                (View ORCID Profile)
                (View ORCID Profile)
                (View ORCID Profile)
                (View ORCID Profile)
                Journal
                Expert Review of Hematology
                Expert Review of Hematology
                1747-4086
                1747-4094
                March 15 2023
                March 15 2023
                March 15 2023
                : 16
                : sup1
                : 55-70
                Affiliations
                [1 ]Center for Inherited Blood Disorders, Orange, California, USA
                [2 ]Pediatric Hematology Division, Department of Pediatrics, University of California at Irvine, Children's Hospital of Orange County, Irvine, California, USA
                [3 ]Hemostasis and Thrombosis Center, Northwell Health, New Hyde Park, New York, New York, USA
                [4 ]Center for Bleeding and Clotting Disorders, M Health Fairview, Minneapolis, Minnesota, USA
                [5 ]Ultragenyx Pharmaceutical Inc Novato, California, USA
                [6 ]Plasminogen Deficiency Foundation, Durham, North Carolina, USA
                [7 ]National Hemophilia Foundation, New York, New York, USA
                [8 ]Sigilon Therapeutics, Cambridge, Massachusetts, USA
                [9 ]Patient author, Lived Experience Expert, Dearborn, Michigan, USA
                [10 ]Hamilton Regional Laboratory Medicine Program, Hamilton Health Sciences, Hamilton, Ontario, Canada
                [11 ]Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada
                [12 ]Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA
                [13 ]Angelo Bianchi Bonomi Hemophilia and Thrombosis Center and Fondazione Luigi Villa, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy
                [14 ]Oncology Support Service, Providence Alaska Medical Center, Anchorage, Alaska, USA
                [15 ]Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy
                [16 ]Comprehensive Hemophilia Center, Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA
                [17 ]American Thrombosis and Hemostasis Network, Rochester, New York, USA
                [18 ]The Hemophilia Center, Oregon Health & Science University, Portland, Oregon, USA
                [19 ]Hemab Therapeutics, Copenhagen, Denmark
                [20 ]Bleeding and Clotting Disorders Institute, Peoria, Illinois, USA
                [21 ]Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
                [22 ]UNC Blood Research Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
                [23 ]Indiana Hemophilia and Thrombosis Center, Indianapolis, Indiana, USA
                Article
                10.1080/17474086.2023.2175661
                47765b60-9d54-49b5-9489-3651f3318c87
                © 2023

                http://creativecommons.org/licenses/by-nc-nd/4.0/

                History

                Comments

                Comment on this article